Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2571 of 5804
-
Can Real-Time checks during leg bypass save limbs?
Knowledge-focused Recruiting nowThe goal of the study is to identify and validate flow measurement and ultrasound images in patients undergoing vein bypass surgery below-knee and above ankle
Sponsor: Medistim ASA • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
New study monitors Real-World use of LIVTENCITY for Post-Transplant CMV
Disease control Recruiting nowCytomegalovirus (CMV) is a common virus that infects many people. It can cause serious illness in people with weak immune systems especially in those undergoing transplants. LIVTENCITY (Maribavir) is a medicine approved for treating CMV infection in adults after transplant in Sou…
Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Quit nicotine, get reconstruction: new study offers hope for breast cancer patients
Symptom relief Recruiting nowClose to 20% of cancer patients currently use nicotine products. Nicotine use in breast cancer patients is associated with poorer overall outcomes, including worsened survival and increased surgical complications. Nicotine cessation is rarely addressed in breast cancer patients a…
Phase: NA • Sponsor: University of Florida • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Could a simple drink ease Parkinson's constipation?
Symptom relief OngoingConstipation is a common complication and non-motor symptom of Parkinson's disease (PD) and affects up to 80% of people with PD. It is in fact within the non-motor symptoms that nutrition and dietetic intervention could have the greatest impact. Research suggests that increasing …
Phase: NA • Sponsor: University of Ulster • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
New dosing strategy for PAH drug under study
Disease control CompletedResearchers are looking for other ways to treat people with PAH. In PAH, the blood vessels in the lungs become thick and narrow, which makes it harder for blood to flow to the lungs. The goal of the study is to learn: * What happens to different doses of sotatercept in a person…
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Second chance: new procedure aims to lower blood sugar in stubborn diabetes
Disease control OngoingThe purpose of this study is to test the hypothesis that re-treatment of the duodenal mucosa with RF vapor ablation will result in improvement in glycemic parameters, without complications (bleeding/ stricture / perforation) among subjects who failed to show improvement after ini…
Phase: NA • Sponsor: Aqua Medical, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Spinal stimulation and robot suit aim to get people with paralysis walking better
Disease control Recruiting nowThis study is aimed to evaluate whether transcutaneous spinal cord stimulation (tSCS) can augment robotic gait training (RGT) to improve functional mobility in participants with chronic spinal cord injuries. It also evaluate the impact of the tSCS+RGT on health-related quality of…
Phase: NA • Sponsor: National University Hospital, Singapore • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New hospital program aims to keep COPD patients out of trouble after Flare-Ups
Disease control OngoingThis is a cluster randomized interventional study. Intervention is implemented at a hospital level and will change overall daily practice. 36 county level hospitals are r an domized to the intervention group or control group at the ratio of 2:1 . Total subjects is 1368 and a size…
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New cancer drug SHR-3821 enters first human trial
Disease control Recruiting nowThis is an open label, multi-center, multiple dose Phase I study to evaluate the safety, tolerability, pharmacokinetics and efficacy of SHR-3821 injection in subjects with advanced solid tumors.
Phase: PHASE1 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Could a common gut supplement boost weight loss in diabetes?
Disease control CompletedThe goal of this clinical trial (randomized controlled trial with parallel group design) is to evaluate the effects of oral sodium butyrate supplementation for 12 weeks, compared with placebo, in addition to a moderately hypocaloric diet, on body weight, body composition, glucose…
Phase: NA • Sponsor: Federico II University • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New drug cocktail aims to tackle Hard-to-Treat cancers
Disease control Recruiting nowThe goal of this clinical trial is to learn the safety, tolerability, pharmacokinetic characteristics and efficacy of FC084CSA in combination with Tislelizumab in patients with advanced malignant solid tumors.
Phase: PHASE1, PHASE2 • Sponsor: FindCure Biosciences (ZhongShan) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New program aims to break the cycle of opioid addiction and incarceration for women
Disease control CompletedOpioid-related overdose deaths and incarceration rates have skyrocketed and have disproportionately affected women. Despite having a higher burden of substance use disorders and HIV/AIDS than criminal justice-involved (CJI) men, CJI women are less likely to have access to substan…
Phase: NA • Sponsor: Abenaa Jones, Ph.D. • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New drug may offer quicker relief for ER patients with nausea
Symptom relief Recruiting nowThe study team proposes a randomized, double-blind, RCT to address the following goal: to determine the relative efficacy and adverse event profile of fosaprepitant compared to the standard of care antiemetic ondansetron. Fosaprepitant and its active metabolite aprepitant are a r…
Phase: PHASE2, PHASE3 • Sponsor: Montefiore Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
New study aims to give kidney patients real choices beyond dialysis
Knowledge-focused ENROLLING_BY_INVITATIONThe goal of this clinical trial is to compare two health system-based approaches for offering kidney failure treatment options to older patients with kidney failure, specifically, to ensure patients are actively involved in a shared decision making (SDM) process covering a full r…
Phase: NA • Sponsor: George Washington University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
New drug THE-0504 enters human testing for tough cancers
Disease control Recruiting nowSingle-centre, open-label, dose escalation phase I clinical trial, designed to evaluate mainly the safety and tolerability of the antitumor drug THE-0504 in patients with different types of solid tumors.
Phase: PHASE1 • Sponsor: Thena Biotech S.r.l. • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New study tests simple exercises and gadget to stop Post-Baby leaks
Symptom relief Recruiting nowThis is a multi-center, randomized single-blind nonsurgical trial conducted in approximately 216 primiparous postpartum women at high risk for prolonged/sustained pelvic floor disorders with symptomatic, bothersome urinary incontinence (UI) amenable to nonsurgical treatment. TUL…
Phase: NA • Sponsor: NICHD Pelvic Floor Disorders Network • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
New antibiotic may outperform standard care in preventing surgical infections
Prevention Recruiting nowAnesthesia and surgical guidelines recommend the administration of a surgical antibiotic prophylaxis for patients undergoing "clean" surgery. The prescribed antibiotic should target the bacteria most commonly found in surgical site infections (SSIs) and the duration of administra…
Phase: PHASE4 • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Prevention
Last updated Jun 27, 2026 09:02 UTC
-
New app aims to tame anger in veterans with PTSD
Symptom relief Recruiting nowDifficulty controlling anger is the most commonly reported reintegration concern among combat Veterans, especially those with a diagnosis of posttraumatic stress disorder (PTSD). Problematic anger is associated with significant functional impairment. In the current project, the i…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
New eye injection shows promise for blinding swelling
Disease control OngoingEYE-TIE-201 is a 2-part study to investigate the safety and effectiveness of a new drug being developed called EYE201. All participants in the study will receive a total of 3 injections of EYE201 into the study eye, spaced at 4 weeks apart. In the first part, termed the multipl…
Phase: PHASE1, PHASE2 • Sponsor: EyeBiotech Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Can extra doctor visits after birth save Mothers' hearts?
Disease control OngoingThe United States is in the midst of a maternal mortality and morbidity crisis, with more than half of maternal deaths occurring within the first postpartum year. Patients with hypertensive disorders of pregnancy (HDP) and diabetes have been found to be particularly high-risk, as…
Phase: NA • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC